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Case #1
A 32-year-old Caucasian man, without significant past 
medical history, presented to the Emergency Department 
with syncope while shoveling snow. No signs of  congestive 
heart failure were noted on physical exam. An initial elec-
trocardiogram (ECG) showed sinus rhythm, first-degree AV 
block, right-bundle branch block (RBBB), and left posterior 
hemiblock. Chest radiography revealed perihilar fullness 
and diffuse pulmonary nodular opacities (Fig. 1). Coronary 
arteries were normal on angiography. Cardiovascular mag-
netic resonance (CMR) was performed to further evaluate 
the myocardium for possible infiltrative process. Steady-
state free-precession (SSFP) images were remarkable for 
thickened myocardium and severely depressed biventricular 
systolic function, with a calculated right ventricular ejection 
fraction (RV EF) of  27% and left ventricular ejection frac-
tion (LV EF) of  30%. Postgadolinium, phase-sensitive in-
version recovery (PSIR) images demonstrated diffuse areas 
of  abnormal delayed hyper-enhancement (DHE) within the 
left ventricular myocardium in an epicardial/midwall dis-
tribution consistent with nonischemic cardiomyopathy (Fig. 
2). Turbo-spin-echo (TSE) imaging with T2 weighting re-
vealed scattered areas of  increased signal intensity, most 
prominent in the interventricular septum, suggesting 
edema. In addition, axial images of  the chest revealed en-
larged mediastinal lymph nodes and bilateral pulmonary 
abnormalities with perihilar predominance. Overall find-
ings were highly suggestive of  sarcoidosis, with areas of  
active inflammation. 
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Figure 1. 32-year-old Caucasian man with cardiac and pul-
monary sarcoidosis (case #1). AP chest x-ray. Note perihilar 
fullness and bilateral nodular opacities.
A transbronchial biopsy confirmed the diagnosis of  sar-
coidosis. Subsequently, positron-emission tomography 
(PET-FDG) imaging confirmed active disease in the medi-
astinal lymph nodes and myocardium (Fig. 3). The patient 
was started on systemic steroids and methotrexate. Since 
the trifascicular block was presumed to be the cause of  the 
syncope, in the context of  severe biventricular dysfunction 
and cardiac sarcoidosis, an implantable cardioverter–defi-
brillator (ICD) was implanted to prevent sudden death. 
Following ICD placement, the patient had three episodes of 
ventricular tachycardia during the first month, two of  them 
requiring a shock. 
Case #2 
A 57-year-old, previously healthy African-American man 
presented to the Emergency Department with recurrent 
palpitations and syncope. No signs of  congestive heart fail-
ure were noted on physical exam. Holter monitoring dem-
onstrated episodes of  sustained and nonsustained mono-
morphic ventricular tachycardia, which was the presumed 
cause of  syncope. Echocardiography was notable for thick-
ening and increased echogenicity involving the distal half  of 
the left and right ventricles, and mild hypokinesis of  the 
interventricular septum (Fig. 4). CMR revealed diffuse 
biventricular wall thickening, with associated extensive 
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Figure 2. 32-year-old man with cardiac and pulmonary sarcoidosis (case #1). Cardiovascular Magnetic Resonance. A. Phase-
sensitive inversion recovery (PSIR) 4-chamber view shows patchy areas of near-transmural delayed hyperenhancement in a 
nonvascular distribution affecting the basal and mid-septum and basal and mid-lateral segments. B. T2-weighted turbo spin-
echo (TSE) 4-chamber view demonstrates mottled, increased signal intensity in the interventricular septum and lateral wall. C. 
Short-tau inversion recovery (STIR) 4-chamber view demonstrates increased signal intensity at the left ventricular apex con-
sistent with slow flow and heterogeneous signal intensity throughout the interventricular septum and lateral wall. 
Figure 3. 32-year-old man with cardiac and pulmonary sar-
coidosis (case #1). PET-FDG imaging demonstrates in-
creased activity in the mediastinal and bihilar lymph nodes 
as well as the heart.  
Figure 4. 57-year-old man with cardiac and pulmonary sar-
coidosis. Apical 4-chamber transthoracic echocardiogram 
demonstrates increased right and left ventricular apical 
thickness.
DHE involving the apex, mid, and distal segments of  the 
LV and right ventricular (RV) walls (Fig. 5A). T2-weighted 
TSE images showed increased signal in the same segments 
consistent with active inflammation (Fig. 5B). Unlike the 
previous case, this patient demonstrated normal left ven-
tricular function (LV EF 60%) but mildly depressed right 
ventricular systolic function (RV EF 44%). Hilar and medi-
astinal lymphadenopathy was also detected on SSFP im-
ages of  the chest (Figs. 5D, E). MRI findings were again 
highly suggestive of  sarcoidosis with active areas of  in-
flammation. Endomyocardial biopsy of  the RV confirmed 
the suspected MRI diagnosis of  sarcoidosis (Fig. 6). The 
patient was started on systemic steroids. Because of  the 
history of  recurrent episodes of  sustained and nonsustained 
ventricular tachycardia and biopsy-proven diagnosis of  
cardiac sarcoidosis, sotalol was started and an ICD was 
placed. Holter monitoring repeated one month after dis-
charge showed good response to treatment with suppression 
of  arrhythmias.
Discussion
Sarcoidosis is a multisystem granulomatous disease of  
unknown etiology with variable presentation, prognosis, 
and progression. It commonly affects young and middle-
aged patients, with a slightly higher prevalence in women 
(1). The disease has distinct geographic and racial predilec-
tions, with African-Americans and northern Europeans 
commonly affected (1). Approximately 50% of  patients 
with sarcoidosis are asymptomatic, and detection is often 
secondary to prominent mediastinal lymph nodes noted on 
routine chest radiography. Alternately, patients may com-
plain of  dyspnea and persistent cough (25%), and a similar 
percentage has extrathoracic symptoms, usually related to 
the skin or eyes (2). Cardiac involvement produces symp-
toms in only 5% of  patients with sarcoidosis, although 
autopsy and CMR findings suggest myocardial involvement 
in approximately 20% to 50% of  patients (3, 4). Cardiac 
involvement is the initial presentation in 10% to 15% of  
cases. It is an important cause of  death in patients with 
sarcoidosis, causing 30% to 65% of  sarcoidosis-related 
deaths (5). 
In addition to sudden death, cardiac sarcoidosis can pre-
sent with congestive heart failure as well as atrial or ven-
tricular arrhythmias. Cardiac sarcoidosis can affect virtually 
any location of  the conduction system, leading to left- or 
right-bundle branch block (complete or incomplete), atriov-
entricular block of  any degree, and even sinus node arrest. 
Complete heart block is the most common presenting con-
duction abnormality (23% to 30%) and most frequently 
presents as syncope (6). Complete heart block can often 
manifest without any significant evidence of  cardiomyopa-
thy. Both supraventricular and ventricular arrhythmias can 
occur in patients with cardiac sarcoidosis. These arrhyth-
mias are often related to atrial dilatation secondary to left 
ventricular dysfunction or cor pulmonale. Less commonly, 
they may be caused by direct granulomatous involvement 
of  the atria. Ventricular arrhythmias are more common 
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Figure 5. 57-year-old man with cardiac and pulmonary sarcoidosis (case #2). Cardiovascular Magnetic Resonance. A, B. 
Phase-sensitive inversion recovery (PSIR) 4-chamber (left) and Left ventricular Outflow Tract (LVOT) (right) views show diffuse 
areas of delayed hyperenhancement in a nonvascular distribution affecting the apex, mid, and distal segments of the LV and 
right ventricular (RV) walls. C. T2-weighted turbo spin-echo (TSE) 4-chamber view demonstrates mottled, increased signal 
intensity in the interventricular septum and lateral wall. D, E. SSFP images of the chest depict bilateral hilar lymphadenopathy 
(arrows). 
and are usually caused by direct granulomatous involve-
ment of  the myocardium (6). Sudden death, due to either 
ventricular arrhythmia or complete heart block, is the most 
feared cardiac manifestation of  cardiac sarcoidosis. It is 
responsible for 24% to 65% of  all deaths related to cardiac 
sarcoidosis in the United States (6). Importantly, sudden 
death may be the initial presenting manifestation. Corticos-
teroids are the mainstay of  treatment for myocardial sar-
coidosis, in conjunction with ICD placement for patients 
with myocardial dysfunction. The early initiation of  corti-
costeroid therapy may help prevent malignant arrhythmias 
and improve left ventricular function (7). 
The advent and evolution of  noninvasive imaging tech-
nology has aided in the early detection of  sarcoidosis, thus 
permitting earlier initiation of  treatment. Chest radiogra-
phy and computed tomography (CT) can depict hilar and 
mediastinal lymphadenopathy as well as pulmonary ab-
normalities. ECG is used to detect arrhythmias, and 
transthoracic and transesophageal echocardiography are 
useful to assess left ventricular infiltration and/or ventricu-
lar dysfunction. Gallium-67 and PET can detect uptake 
from sarcoidosis; however, the pattern can be nonspecific 
and may mimic other disease processes, including lym-
phoma and diffuse metastatic disease (8). CMR is a particu-
larly versatile tool that can evaluate not only myocardial 
abnormalities (both by tissue characterization and func-
tional assessment) but can also extracardiac manifestations 
of  sarcoid including mediastinal lymphadenopathy and (to 
a limited extent) pulmonary abnormalities. Cardiac sarcoi-
dosis may manifest with areas of  increased signal intensity 
on T2-weighted images, suggesting edema related to active 
disease, and increased signal intensity on postgadolinium 
inversion recovery images, typically in an epicardial or 
midwall distribution (1). On cine imaging, cardiac sarcoido-
sis may exhibit segmental contraction abnormalities and 
areas of  myocardial thinning or thickening, without respect 
for epicardial coronary territories. Confluent sarcoid granu-
lomas may be visible on MRI as nodules with increased 
intra-myocardial signal intensities on both T2-weighted and 
DHE images. 
These two cases included biopsy-proven sarcoidosis and 
an initial presentation of  syncope. Multiple noninvasive 
tests contributed to the eventual diagnosis; however, we 
note in particular the significant advantages of  CMR in the 
characterization of  myocardial involvement, and detection 
of  multi-organ findings of  sarcoidosis. 
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